Acumen Pharmaceuticals (NASDAQ: ABOS)
$3.17
(-0.6%)
-$0.02
Price as of April 26, 2024, 4:00 p.m. ET
Acumen Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Acumen Pharmaceuticals Company Info
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Valuation
Earnings Transcripts
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript
ABOS earnings call for the period ending June 30, 2022.
Motley Fool Transcribing | Aug 15, 2022
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2022 Earnings Call Transcript
ABOS earnings call for the period ending March 31, 2022.
Motley Fool Transcribing | May 16, 2022
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2021 Earnings Call Transcript
ABOS earnings call for the period ending December 31, 2021.
Motley Fool Transcribing | Apr 2, 2022
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.